Biotech Values

[swampboots]

Re: LCTX ( post for archives).
Roach has Lucentis, but me thinks dry macular degeneration field has unmet remedy . ....and reason Roach with Genentech paid 50 million to ensure LCTX's ocular regeneration platform has some partnership and payoff with them, if LCTX scores future successes. This stock has been punched into huge share dilutions, and still had to agree for pittance hand out with highly solvent bettors. However their new expansion routine always deserves a peek ( not "real " money yet IMHO), as payoff in billions. I am deservingly eager for their success, after just having some highly successful cornea epithelium cell replacement therapy, but know too many who have no such immediate totally restorative remedies for their different
challenges...

https://endpts.com/lineage-cell-therapeutics-opens-new-california-rd-facility-and-expands-israel-manufacturing-site/
https://en.wikipedia.org/wiki/Lineage_Cell_Therapeutics